Skip to content

Clinical trials

Recruiting Phase 3 Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 3 Status: Recruiting Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20221
20231
20241
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Amgen1
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
ECRI bv1
Fujian Shengdi Pharmaceutical Co., Ltd.1
Hospital do Coracao1
Icahn School of Medicine at Mount Sinai1
VA Office of Research and Development1
Wenzhou Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis11
Cardiovascular Diseases2
Angina, Unstable1
Cerebral Infarction1
Coronary Artery Disease1
Dyslipidemias1
Heart Diseases1
Intermittent Claudication1
Ischemic Stroke1
Myocardial Infarction1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.